跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PRIVA-ROSUVASTATIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PRIVA-ROSUVASTATIN
Authorized
STANDARD
PRIVA-ROSUVASTATIN
PHARMAPAR INC
🇨🇦 Health Canada
Approval Date
Apr 6, 2026
Approval ID
9ebb39fdcb8fee3b
Company
PHARMAPAR INC
Type
Standard
Approval Details
Approval Id
9ebb39fdcb8fee3b
Drug Approval Canada Name
PRIVA-ROSUVASTATIN
Product Name
PRIVA-ROSUVASTATIN
Status
Cancelled Post Market
Status Date
2022-09-27
Original Market Date
2016-06-30
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
PRESCRIPTION
Ahfs
24:06.08
Atc Original
C10AA07 ROSUVASTATIN
Aig Number
0148963002
Company Name
PHARMAPAR INC
Company Address
1565 Boul Lionel-Boulet Varennes Quebec Canada J3X 1P7
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Apr 6, 2026
Approval ID
9ebb39fdcb8fee3b
Type
Standard
Back to Health Canada Approvals